CONTEXT: An august meeting of medical societies in Brussels to debate a few interesting topics for our discerning readers | Firstly the implications of the new IVD regulations which are definitely worth delving into…and then there is the importance of evidence-based medicine as health policies are shaped across Europe in this post-Covid world.
IMPACT: High
READ TIME: 3 mins
Quality Level Mean [1 – 10]: 7
1. “Professor Piotr Szymanski, Chair of the ESC Regulatory Affairs Committee says: “The ESC has been a pioneer in providing scientific input to the European Commission through our participation in a number of EU expert groups.”
2. “Brussels, 22 April 2021: Today medical societies will put forward the case for more robust, evidence-based EU health policies during a meeting of the European Parliament’s Science and Technology Options Assessment Panel1.”
3. “Experts from the Biomedical Alliance in Europe2, the European Society of Cardiology3, the European Hematology Association4 and the European Federation of Clinical Chemistry and Laboratory Medicine5 will contribute to an online workshop with the European Commission and Members of the European Parliament.”
4. “Professor Alan Fraser, Chair of the Task Force on Regulatory Affairs, BioMed Alliance says: “European medical societies can play a very important role in supporting the development of evidence-based health policy.”
5. “It is crucial to ensure that medical experts are more consistently involved throughout the EU decision-making process to compensate for the limited in-house scientific expertise of the European Commission and the European Parliament.””